END-OF-YEAR DRIVE: HOW YOU CAN HELP SUPPORT LOCAL NEWS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

181.92 -1.08 (-0.59%)
Streaming Delayed Price Updated: 3:33 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
What 5 Analyst Ratings Have To Say About Icon ↗
 
Via Benzinga
News headline image
ICON plc Schedules First Quarter 2023 Earnings Conference Call
From ICON plc
Via Business Wire
News headline image
2 Clinical Research Stocks That Could Grow by More Than 10% This Year, and 1 to Watch ↗
These companies strive to bring down the cost of developing new therapies. 
Via The Motley Fool
News headline image
Should You Bring The Luck Of The Irish To Your Investmets?
An index of Irish stocks is outperforming the S&P 500 this year, with large, U.S.-listed companies such as Ryan Air and CRH among top price performers. 
Via MarketBeat
Topics ETFs Stocks
News headline image
Earnings Preview For Icon ↗
 
Via Benzinga
News headline image
Hopeful Golden Cross Forms On Icon's Chart ↗
 
Via Benzinga
The Latest Analyst Ratings for Icon ↗
 
Via Benzinga
News headline image
Where Icon Stands With Analysts ↗
Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Catalent Stock Showing Improved Relative Strength Rating ↗
On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74. 
Via Investor's Business Daily
News headline image
ICON plc to Present at Upcoming Investor Conferences
From ICON plc
Via Business Wire
News headline image
ICON Reports Fourth Quarter and Full Year 2022 Results
From ICON plc
Via Business Wire
News headline image
The 7 Best Growth Stocks to Buy for February 2023 ↗
Some of the best growth stocks are lesser-known names that have the ability to provide tremendous long-term upside for investors. 
Via InvestorPlace
News headline image
Where Icon Stands With Analysts ↗
Analysts have provided the following ratings for Icon (NASDAQ:ICLR) within the last quarter: 
Via Benzinga
News headline image
Analyst Ratings for Icon ↗
Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Icon ↗
Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
From ICON plc
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023 ↗
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023 ↗
 
Via Benzinga
News headline image
ICON Issues Financial Guidance for Full Year 2023
From ICON plc
Via Business Wire
News headline image
ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ICON plc
Via Business Wire
News headline image
ICON recognised as leading contract research organisation and employer by Scrip, Fierce Life Sciences, Financial Times and others
From ICON plc
Via Business Wire
News headline image
ICON plc to Present at the 2022 Evercore ISI HealthCONx Conference
From ICON plc
Via Business Wire
News headline image
Jim Cramer Says This Stock Down 25% This Year Is 'Not To Be Touched, Because They're Doing Very Poorly' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said AST SpaceMobile Inc (NASDAQ: ASTS) is an "exciting thing, not a stock. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2022 ↗
Upgrades 
Via Benzinga
News headline image
ICON Reports Third Quarter 2022 Results
From ICON plc
Via Business Wire
News headline image
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging. 
Via Investor's Business Daily
News headline image
ICON selected by BARDA to conduct anthrax vaccine clinical trial
From ICON plc
Via Business Wire
News headline image
ICON plc Schedules Third Quarter 2022 Earnings Conference Call
From ICON plc
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
ICON Releases its 2021 ESG Report
From ICON plc
Via Business Wire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article